Nyxoah Discloses Total Number of Shares and Voting Rights
Nyxoah SA announced on June 30, 2026, the issuance of new shares following the exercise of restricted share units. The company's share capital now stands at EUR 7,075,152.31.
Mont-Saint-Guibert, Belgium – Nyxoah SA, a medical device company, disclosed its total number of shares and voting rights in a press release dated June 30, 2026. The company reported the issuance of 146,531 new ordinary shares on June 30, 2026, resulting from the exercise of restricted share units.
The company's share capital amounts to EUR 7,075,152.31. The total number of securities carrying voting rights is 100,072,815, all of which are ordinary shares. This also represents the total number of voting rights, serving as the denominator for future disclosures.
Nyxoah also stated that there are 3,731,884 rights to subscribe to securities carrying voting rights that have not yet been issued. This figure excludes 36,125 subscription rights that have been issued but not yet granted.
Furthermore, the company has 225 convertible bonds, each with a nominal value of EUR 83,000. The conversion of all these bonds at the current revised price of EUR 1.48 per share could result in 12,618,243 voting rights, not accounting for interest conversion.